Skip to search formSkip to main contentSkip to account menu

Clivarine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Reviparin sodium (clivarine) is a second generation LMWH, developed with the aim of maximising the antithrombotic action while… 
2004
2004
Objective To observe the effect of Clivarine(low-molecular-weight heparin)on the treatment of acute cerebral in-farction during… 
Review
2002
Review
2002
Reviparin sodium (Clivarine®, Knoll AG) is a low molecular weight heparin (LMWH) with a mean peak molecular weight of 3900 Da. It… 
1996
1996
Our previous experimental studies on rats motionless for 7 to 60 days in special devices limiting their movements revealed a… 
1996
1996
UNLABELLED Our paper represents a synopsis of the main mechanisms by which low-molecular-weight heparins act as pharmacodynamic…